Literature DB >> 29777390

Synergistic effect of TRAIL and irradiation in elimination of glioblastoma stem-like cells.

Junfeng Liu1, Qinglei Gao2,3, Tao Xie1, Yu Liu1, Longjun Luo1, Cheng Xu1, Lu Shen3, Feng Wan1, Ting Lei1, Fei Ye4.   

Abstract

Glioblastoma multiforme (GBM) is the most common malignancy in central nervous system. A small subpopulation of GBM cells known as GBM stem-like cells (GSLCs) were supposed to be the most malignant cells among GBM cells as they are resistant to multiple therapies including radiotherapy. In this study, we set up two GSLCs cell lines from the two parental U87 and U251 glioma cell lines, and studied the expression of apoptosis-related genes alteration in GSLCs before and after irradiation. We found that one of the receptors of TNF-related apoptosis-inducing ligand (TRAIL), DR5, was dramatically up-regulated in GSLCs after irradiation (IR). Although GSLCs are resistant to both TRAIL and radiation treatment alone, the combined treatment with TRAIL and irradiation achieved maximum killing effect of GSLCs due to inducing the expression of DR5 and inhibiting the expression of cFLIP. Therefore, TRAIL and IR combined treatment would be a simple but practical therapeutic strategy for clinical application.

Entities:  

Keywords:  DR5; Glioblastoma; Irradiation; Radioresistance; Stem-like cells; TRAIL

Mesh:

Substances:

Year:  2018        PMID: 29777390     DOI: 10.1007/s10238-018-0504-7

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  39 in total

Review 1.  An intermittent approach for cancer chemoprevention.

Authors:  Xiangwei Wu; Scott M Lippman
Journal:  Nat Rev Cancer       Date:  2011-11-10       Impact factor: 60.716

Review 2.  Surviving apoptosis: life-death signaling in single cells.

Authors:  Deborah A Flusberg; Peter K Sorger
Journal:  Trends Cell Biol       Date:  2015-04-25       Impact factor: 20.808

3.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

Review 4.  Essential role of Gli proteins in glioblastoma multiforme.

Authors:  Matteo Santoni; Luciano Burattini; Massimo Nabissi; Maria Beatrice Morelli; Rossana Berardi; Giorgio Santoni; Stefano Cascinu
Journal:  Curr Protein Pept Sci       Date:  2013-03       Impact factor: 3.272

5.  Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP.

Authors:  Lijuan Ding; Changji Yuan; Feng Wei; Guangyi Wang; Jing Zhang; Anita C Bellail; Zhaobin Zhang; Jeffrey J Olson; Chunhai Hao
Journal:  Cancer Invest       Date:  2011-08-30       Impact factor: 2.176

6.  Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation.

Authors:  David Capper; Timo Gaiser; Christian Hartmann; Antje Habel; Wolf Mueller; Christel Herold-Mende; Andreas von Deimling; Markus David Siegelin
Journal:  Acta Neuropathol       Date:  2009-02-12       Impact factor: 17.088

7.  Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation.

Authors:  C J Henrich; A D Brooks; K L Erickson; C L Thomas; H R Bokesch; P Tewary; C R Thompson; R J Pompei; K R Gustafson; J B McMahon; T J Sayers
Journal:  Cell Death Dis       Date:  2015-02-26       Impact factor: 8.469

8.  Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.

Authors:  Gila Kazimirsky; Wei Jiang; Shimon Slavin; Amotz Ziv-Av; Chaya Brodie
Journal:  Stem Cell Res Ther       Date:  2016-10-10       Impact factor: 6.832

Review 9.  Cancer stem cell contribution to glioblastoma invasiveness.

Authors:  Barbara Ortensi; Matteo Setti; Daniela Osti; Giuliana Pelicci
Journal:  Stem Cell Res Ther       Date:  2013-02-28       Impact factor: 6.832

10.  BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.

Authors:  Chang-Nim Im; Hye Hyeon Yun; Byunghoo Song; Dong-Ye Youn; Mei Nu Cui; Hong Sug Kim; Gyeong Sin Park; Jeong-Hwa Lee
Journal:  Oncotarget       Date:  2016-06-07
View more
  1 in total

1.  IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells.

Authors:  Sodai Yoshimura; Emiko Sano; Yuya Hanashima; Shun Yamamuro; Koichiro Sumi; Takuya Ueda; Tomohiro Nakayama; Hiroyuki Hara; Atsuo Yoshino; Yoichi Katayama
Journal:  Oncol Rep       Date:  2019-10-22       Impact factor: 3.906

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.